Afficher la notice abrégée

dc.contributor.editorLee, Bae Hwan
dc.date.accessioned2022-01-11T13:45:35Z
dc.date.available2022-01-11T13:45:35Z
dc.date.issued2021
dc.identifierONIX_20220111_9783036519944_633
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/76898
dc.description.abstractDear Colleagues, The brain is vulnerable to injury. Following injury in the brain, apoptosis or necrosis may occur easily, leading to various functional disabilities. Neuronal death is associated with a number of neurological disorders including hypoxic ischemia, epileptic seizures, and neurodegenerative diseases. The brain subjected to injury is regarded to be responsible for the alterations in neurotransmission processes, resulting in functional changes. Oxidative stress produced by reactive oxygen species has been shown to be related to the death of neurons in traumatic injury, stroke, and neurodegenerative diseases. Therefore, scavenging or decreasing free radicals may be crucial for preventing neural tissues from harmful adversities in the brain. Neurotrophic factors, bioactive compounds, dietary nutrients, or cell engineering may ameliorate the pathological processes related to neuronal death or neurodegeneration and appear beneficial for improving neuroprotection. As a result of neuronal death or neuroprotection, the brain undergoes activity-dependent long-lasting changes in synaptic transmission, which is also known as functional plasticity. Neuroprotection implying the rescue from neuronal death is now becoming one of global health concerns. This Special Issue attempts to explore the recent advances in neuroprotection related to the brain. This Special Issue welcomes original research or review papers demonstrating the mechanisms of neuroprotection against brain injury using in vivo or in vitro models of animals as well as in clinical settings. The issues in a paper should be supported by sufficient data or evidence. Prof. Bae Hwan Lee Guest Editor
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.otherglobal cerebral ischemia
dc.subject.otheramiloride
dc.subject.othersodium–hydrogen exchanger-1
dc.subject.otherzinc
dc.subject.otherneuronal death
dc.subject.otherneuroprotection
dc.subject.otherneurodegenerative disorder
dc.subject.othercholine acetyltransferase (ChAT)
dc.subject.othertrimethyltin (TMT)
dc.subject.otherbean phosphatidylserine (Bean-PS)
dc.subject.otherbrain-derived neurotrophic factor
dc.subject.othermoderate hypoxia
dc.subject.otherphysical exercise
dc.subject.otherpsychomotor function
dc.subject.otherreaction time
dc.subject.othercortisol
dc.subject.othercatecholamines
dc.subject.othernitrite
dc.subject.otherendotheline-1
dc.subject.otherlactate
dc.subject.otherpyridoxine deficiency
dc.subject.otherischemia
dc.subject.othergerbil
dc.subject.otherhomocysteine
dc.subject.othercell death
dc.subject.otherglia
dc.subject.otherneurogenesis
dc.subject.otherN-acetyl-l-cysteine
dc.subject.othertransient receptor potential melastatin 2
dc.subject.otherneurodegeneration
dc.subject.otherAlzheimer’s disease
dc.subject.othermetabolic disease
dc.subject.otheradiponectin
dc.subject.otherinsulin
dc.subject.otherantioxidants
dc.subject.otherstroke
dc.subject.otherpreventive gene therapy
dc.subject.otheradenoviral vector
dc.subject.otherVEGF
dc.subject.otherGDNF
dc.subject.otherNCAM
dc.subject.otherhuman umbilical cord blood mononuclear cells
dc.subject.otherantioxidant
dc.subject.otherbrain
dc.subject.otherneurodegenerative disease
dc.subject.otheroxidative stress
dc.subject.otherPGC-1α
dc.subject.othervascular endothelial growth factor
dc.subject.othervascular endothelial growth factor receptor 2
dc.subject.otherPI3K/AKT
dc.subject.otherMEK/ERK
dc.subject.otherstatus epilepticus
dc.subject.otherhippocampus
dc.subject.othermiddle cerebral artery occlusion
dc.subject.otherreperfusion injury
dc.subject.otherlipid emulsion
dc.subject.otherexcitotoxicity
dc.subject.otherapoptosis
dc.subject.otherGPR4 receptor
dc.subject.otherMPP+
dc.subject.otherParkinson’s disease
dc.subject.otherCRISPR/cas9
dc.subject.otherischemic stroke
dc.subject.otherblood brain barrier
dc.subject.othernanoparticle-based drug delivery
dc.subject.otherbrain targeting
dc.subject.otherBDNF
dc.subject.othermiRNAs
dc.subject.othersynaptic plasticity
dc.subject.otherdepression
dc.subject.otherglioblastoma
dc.subject.otherastrocytes
dc.subject.otherastrocytic networks
dc.subject.otherconnexin 43
dc.subject.othercalcium activity
dc.subject.otherneural injury
dc.subject.othernimodipine
dc.subject.othersubarachnoid haemorrhage
dc.subject.otheracid-sensing ion channels
dc.subject.otheroxygen-glucose deprivation
dc.subject.otherliver growth factor
dc.subject.otherinflammation
dc.subject.othermicroglia
dc.subject.otherTg2576 transgenic mice
dc.subject.otheramyloid-beta
dc.subject.otheroculomotor system
dc.subject.othertrophic factors
dc.subject.othermotoneurons
dc.subject.otheraxotomy
dc.subject.otheramyotrophic lateral sclerosis
dc.subject.otherelectroneutral transport
dc.subject.othercation-chloride cotransporters
dc.subject.otherKCCs
dc.subject.otherNKCCs
dc.subject.otherWNK-SPAK/OSR1
dc.subject.otherascorbic acid
dc.subject.otheraging
dc.subject.otherorganotypic hippocampal slice culture
dc.subject.othern/a
dc.titleNeuroprotection: Rescue from Neuronal Death in the Brain
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-1995-1
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036519944
oapen.relation.isbn9783036519951
oapen.pages408
oapen.place.publicationBasel, Switzerland


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/